Context Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $25,072,616.
Profit Margin
| 2019 | 0 | -7.48M | |
|---|---|---|---|
| 2020 | 0 | 6.64M | |
| 2021 | 0 | -7.43M | |
| 2022 | 0 | -14.29M | |
| 2023 | 0 | -23.96M |
CNTX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 12.04K | 9.26K | 0 | 0 | 0 |
Gross profit | -12.04K | -9.26K | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 17.78M | 7.09M | 3.80M | 1.64M | 2.41M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 25.07M | 14.88M | 7.43M | 2.57M | 5.37M |
Operating income | -25.07M | -15.38M | -10.52M | -2.57M | -5.37M |
Other income (expenses), net | 1.10M | 545.26K | 68.94K | 9.21M | -1.00M |
Income before tax | -23.96M | -14.83M | -10.45M | 6.64M | -6.38M |
Income tax expense | 0 | -545.26K | -3.02M | 661.22K | 1.10M |
Net income | -23.96M | -14.29M | -7.43M | 6.64M | -7.48M |
Earnings per share | |||||
Basic EPS | -1.5 | -0.9 | -0.47 | 0.61 | -0.68 |
Diluted EPS | -1.5 | -0.9 | -0.47 | 0.61 | -0.68 |
| Data source | Data source | Data source |